The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,339K data for 617K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

21 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Arylsulfonamide pyrimidines as VLA-4 antagonists.EBI
Elan Pharmaceuticals
Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101)--a small molecule antagonist of leukocyte function associated antigen-1.EBI
Cerep
Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye.EBI
TBA
Identification of novel agonists of the integrin CD11b/CD18.EBI
Department Of Medicine And University Of Miami
Fragment-based drug discovery.EBI
Sunesis Pharmaceuticals
Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agents.EBI
Genentech
Structure-activity relationship (SAR) of thea-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists.EBI
Sunesis Pharmaceuticals
Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonists.EBI
Sunesis Pharmaceuticals
De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold.EBI
Cerep
Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-alpha]imidazol-2-one derivatives.EBI
Boehringer Ingelheim Pharmaceuticals
Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.EBI
Novartis Institutes For Biomedical Research
1,4-Diazepane-2-ones as novel inhibitors of LFA-1.EBI
Novartis Institute For Biomedical Research
Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 4. Structure-activity relationship of substituents on the benzene ring of the cinnamide.EBI
Abbott Laboratories
Discovery of potent antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 3. Amide (C-ring) structure-activity relationship and improvement of overall properties of arylthio cinnamides.EBI
Abbott Laboratories
Discovery and SAR of diarylsulfide cyclopropylamide LFA-1/ICAM-1 interaction antagonists.EBI
Abbott Laboratories
Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 2. Mechanism of inhibition and structure-based improvement of pharmaceutical properties.EBI
Abbott Laboratories
Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 1. Identification of an additional binding pocket based on an anilino diaryl sulfide lead.EBI
Abbott Laboratories
Discovery and evaluation of potent, tyrosine-based alpha4beta1 integrin antagonists.EBI
Celltech Chiroscience
Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.EBI
Biogen
Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonists.EBI
Dupont Pharmaceuticals
Novel thiazole based heterocycles as inhibitors of LFA-1/ICAM-1 mediated cell adhesion.EBI
R. W. Johnson Pharmaceutical Research Institute